MAXVALUE CREDITS AND INVESTMENTS LIMITED
Max India Limited is a multi-business corporate, driven by the spirit of enterprise and focused on people and service-oriented businesses. The Company’s vision is to be one of India’s most admired corporates for Service Excellence. It is a manufacturer of specialty plastic film products for packaging industry. The Company has invested in various subsidiaries in diversified businesses, such as healthcare, life insurance, health insurance, clinical research, etc. The Company is in the business of clinical research services to global pharmaceuticals, device and biotechnology companies through its 100% wholly owned subsidiary Max Neeman Medical International Limited (MNMI). The Company has two segments: Specialty Plastic products and Business Investments.
Financial Summary (Amount in Rupees)
| Description | 2020-21 | 2019-20 |
| Total Income | 1,54,11,22,731 | 1,85,21,57,403 |
| Total Expenditure | 1,54,55,29,239 | 1,84,65,70,915 |
| Profit before prior period items and tax | (44,06,508) | 55,86,488 |
| Prior period items | 0 | 0 |
| Profit before tax | 17,54,054 | 55,86,488 |
| Less: Deferred Tax | (66,95,285) | (83,57,698) |
| Profit for the Year | 2,42,09,339 | 1,39,44,186 |
Ensuring Business Continuity during the Pandemic
Company’s digitalisation initiatives proved beneficial in the times of Covid-19 spread. Since the mandatory lockdown due to Covid-19 pandemic, customers could continue doing all transactions online such as interest/ loan amount payment, top up of loan, etc except new pledge and release of ornaments. All the critical business applications such as core banking solution (CBS), HR systems, etc were ensured running smoothly. The entire IT teams involved in monitoring and support are provided work from home (WFH) with appropriate information security controls in place. Also, to protect the data, VPN and DLP tools were used for the WFH client devises.
CONSOLIDATED
INCOME STATEMENT
BALANCE SHEET
| Equities & Liabilities | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|
|
Share Capital
|
53 | 53 | 53 | 53 | 53 | |
|
Reserves & Surplus
|
2,092 | 2,005 | 1,765 | 2,281 | 1,911 |
|
|
Current Liabilities
|
2,311 | 2,302 | 2,098 | 5,195 | 1,400 |
|
|
Other Liabilities
|
70,068 | 62,849 | 51,923 | 39,208 | 34,780 |
|
|
Total Liabilities
|
74,526 | 67,210 | 55,841 | 46,739 | 38,146 |
|
| Assets | ||||||
|---|---|---|---|---|---|---|
|
Fixed Assets
|
115 | 30 | 31 | 168 | 176 |
|
|
Current Assets
|
71,339 | 65,414 | 54,652 | 6,368 | 3,926 |
|
|
Other Assets
|
3,071 | 1,766 | 1,157 | 40,202 | 34,043 |
|
|
Total Assets
|
74,526 | 67,210 | 55,841 | 46,739 | 38,146 |
|
| Other Info | ||||||
|---|---|---|---|---|---|---|
|
Contingent Liabilities
|
123 | 164 | 332 | 474 | 573 |
|
CASH FLOW
| Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | ||
|---|---|---|---|---|---|---|
|
Operating Activities
|
9,467 | 8,826 | 7,533 | 6,525 | 3,802 |
|
|
Investing Activities
|
-9,008 | -8,789 | -6,951 | -6,289 | -3,503 | |
|
Financing Activities
|
-380 | -173 | -116 | -215 | -186 | |
|
Others
|
0 | 0 | 0 | 0 | 0 |
|
|
Net Cash Flow
|
78 | -136 | 465 | 20 | 112 |
|
GROWTH RATIO
| Growth Ratios | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|
|
3 Yr CAGR Sales (%)
|
9.44 | 29.11 | 5.01 | 14.45 | 5.23 |
|
|
3 Yr CAGR Net Profit (%)
|
-32.18 | 2.92 | 10.04 | 68.29 | -31.97 |
|
